Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Transplantation,Hematology
Reference40 articles.
1. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?;Cornelissen;Blood,2007
2. Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis;Gupta;Blood,2013
3. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry;Freytes;Blood,2004
4. Survival for older patients with acute myeloid leukemia: a population-based study;Oran;Haematologica,2012
5. Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States;Medeiros;Ann Hematol,2015
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients;International Journal of Hematology;2021-03-19
2. How old is too old for a transplant?;Best Practice & Research Clinical Haematology;2021-03
3. Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia;Stem Cell Reports;2020-08
4. Assessment of older adult candidates for allogeneic hematopoietic cell transplantation: updates and remaining questions;Expert Review of Hematology;2019-01-22
5. A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia;Leukemia & Lymphoma;2018-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3